Advanced Well-differentiated Neuroendocrine Tumors
| Drug | Drug Name | Drug Description |
|---|
| Drug | Drug Name | Target | Type |
|---|
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB16419 | Ieramilimab | 2 | Completed | 1 |
| DB14892 | Spartalizumab | 2 | Completed | 1 |
| Drug | Drug Name | Drug Description |
|---|
| Drug | Drug Name | Target | Type |
|---|
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB16419 | Ieramilimab | 2 | Completed | 1 |
| DB14892 | Spartalizumab | 2 | Completed | 1 |